GlucoTrack Retained Earnings (Accumulated Deficit) 2011-2024 | GCTK

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

GlucoTrack retained earnings (accumulated deficit) from 2011 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.

GlucoTrack Retained Earnings (Accumulated Deficit) 2011-2024 | GCTK

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$202B
Stryker (SYK)	$147.6B
Boston Scientific (BSX)	$130.8B
Medtronic (MDT)	$113.2B
EssilorLuxottica (ESLOY)	$110B
Lonza Group Ag (LZAGY)	$45.7B
Haleon (HLN)	$42B
GE HealthCare Technologies (GEHC)	$38.8B
ResMed (RMD)	$36.3B
Terumo (TRUMY)	$29.9B
Koninklijke Philips (PHG)	$24.4B
Zimmer Biomet Holdings (ZBH)	$21.9B
Insulet (PODD)	$19.3B
Baxter (BAX)	$17.3B
Smith & Nephew SNATS (SNN)	$10.7B
Bio-Rad Laboratories (BIO)	$10.2B
BellRing Brands (BRBR)	$9.3B
Demant (WILYY)	$8.3B
Lantheus Holdings (LNTH)	$5.9B
TG Therapeutics (TGTX)	$4.8B
Haemonetics (HAE)	$4.7B
ICU Medical (ICUI)	$4.3B
Prestige Consumer Healthcare (PBH)	$4B
Perrigo (PRGO)	$3.6B
Envista Holdings (NVST)	$3.5B
Agios Pharmaceuticals (AGIO)	$3.4B
Neogen (NEOG)	$3.3B
Shandong Weigao Medical Polymer (SHWGF)	$3B
GN Store Nord (GNNDY)	$3B
QuidelOrtho (QDEL)	$2.8B